Canada markets open in 6 hours 38 minutes

Ascendis Pharma A/S (ASND)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
134.00-3.20 (-2.33%)
At close: 04:00PM EDT
133.74 -0.26 (-0.19%)
After hours: 07:05PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.58B
Enterprise Value 7.96B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)21.34
Price/Book (mrq)N/A
Enterprise Value/Revenue 24.18
Enterprise Value/EBITDA -21.93

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 341.15%
S&P500 52-Week Change 324.49%
52 Week High 3161.00
52 Week Low 383.75
50-Day Moving Average 3146.83
200-Day Moving Average 3117.17

Share Statistics

Avg Vol (3 month) 3333.45k
Avg Vol (10 day) 3308.35k
Shares Outstanding 556.61M
Implied Shares Outstanding 658.01M
Float 856.43M
% Held by Insiders 10.76%
% Held by Institutions 1107.38%
Shares Short (Apr 15, 2024) 43.6M
Short Ratio (Apr 15, 2024) 411.55
Short % of Float (Apr 15, 2024) 49.16%
Short % of Shares Outstanding (Apr 15, 2024) 46.36%
Shares Short (prior month Mar 15, 2024) 42.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in EUR.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -152.44%
Operating Margin (ttm)-51.25%

Management Effectiveness

Return on Assets (ttm)-25.51%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)329.02M
Revenue Per Share (ttm)5.82
Quarterly Revenue Growth (yoy)185.50%
Gross Profit (ttm)N/A
EBITDA -354.52M
Net Income Avi to Common (ttm)-501.57M
Diluted EPS (ttm)-9.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)320.24M
Total Cash Per Share (mrq)5.63
Total Debt (mrq)669.01M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.76
Book Value Per Share (mrq)-4.19

Cash Flow Statement

Operating Cash Flow (ttm)-421.9M
Levered Free Cash Flow (ttm)-357.18M